These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10636527)

  • 1. The prognostic implications of outpatient diuretic dose in heart failure.
    Harjai KJ; Dinshaw HK; Nunez E; Shah M; Thompson H; Turgut T; Ventura HO
    Int J Cardiol; 1999 Dec; 71(3):219-25. PubMed ID: 10636527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure.
    Shah RV; McNulty S; O'Connor CM; Felker GM; Braunwald E; Givertz MM
    Am Heart J; 2012 Dec; 164(6):862-8. PubMed ID: 23194486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of diuretic dose in chronic heart failure.
    Martins J; Lourenço P; Araújo JP; Mascarenhas J; Lopes R; Azevedo A; Bettencourt P
    J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):185-91. PubMed ID: 21335479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Compound Hypertonic Saline Solution on Decompensated Heart Failure.
    Wan Y; Li L; Niu H; Ma X; Yang J; Yuan C; Mu G; Zhang J
    Int Heart J; 2017 Aug; 58(4):601-607. PubMed ID: 28701670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diuretic dose and long-term outcomes in elderly patients with heart failure after hospitalization.
    Abdel-Qadir HM; Tu JV; Yun L; Austin PC; Newton GE; Lee DS
    Am Heart J; 2010 Aug; 160(2):264-271.e1. PubMed ID: 20691831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lowering of furosemide dosage after clinical stabilization in patients with congestive heart failure.
    Alexopoulos GP; Anastasiou-Nana MI; Rapti ACh; Margari ZJ; Terrovitis JV; Mitsibounas D; Makri S; Nanas JN
    Acta Cardiol; 2003 Dec; 58(6):513-7. PubMed ID: 14713176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diuretic response in acute heart failure-an analysis from ASCEND-HF.
    ter Maaten JM; Dunning AM; Valente MA; Damman K; Ezekowitz JA; Califf RM; Starling RC; van der Meer P; O'Connor CM; Schulte PJ; Testani JM; Hernandez AF; Tang WH; Voors AA
    Am Heart J; 2015 Aug; 170(2):313-21. PubMed ID: 26299229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lowering furosemide dose in stable chronic heart failure patients with reduced ejection fraction is not accompanied by decompensation: a randomized study.
    Kapelios CJ; Kaldara E; Ntalianis A; Nana E; Pantsios C; Repasos E; Margari Z; Sousonis V; Malliaras K; Nanas JN
    Int J Cardiol; 2014 Dec; 177(2):690-2. PubMed ID: 25304067
    [No Abstract]   [Full Text] [Related]  

  • 11. Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial).
    Mentz RJ; Hasselblad V; DeVore AD; Metra M; Voors AA; Armstrong PW; Ezekowitz JA; Tang WH; Schulte PJ; Anstrom KJ; Hernandez AF; Velazquez EJ; O'Connor CM
    Am J Cardiol; 2016 Feb; 117(3):404-11. PubMed ID: 26704029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal function on admission modifies prognostic impact of diuretics in acute heart failure: a propensity score matched and interaction analysis.
    Matsue Y; Shiraishi A; Kagiyama N; Yoshida K; Kume T; Okura H; Suzuki M; Matsumura A; Yoshida K; Hashimoto Y
    Heart Vessels; 2016 Dec; 31(12):1980-1987. PubMed ID: 26892531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.
    Buckley LF; Carter DM; Matta L; Cheng JW; Stevens C; Belenkiy RM; Burpee LJ; Young MA; Weiffenbach CS; Smallwood JA; Stevenson LW; Desai AS
    JACC Heart Fail; 2016 Jan; 4(1):1-8. PubMed ID: 26656139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diuretic Changes, Health Care Resource Utilization, and Clinical Outcomes for Heart Failure With Reduced Ejection Fraction: From the Change the Management of Patients With Heart Failure Registry.
    Khan MS; Greene SJ; Hellkamp AS; DeVore AD; Shen X; Albert NM; Patterson JH; Spertus JA; Thomas LE; Williams FB; Hernandez AF; Fonarow GC; Butler J
    Circ Heart Fail; 2021 Nov; 14(11):e008351. PubMed ID: 34674536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of loop diuretic dose to mortality in advanced heart failure.
    Eshaghian S; Horwich TB; Fonarow GC
    Am J Cardiol; 2006 Jun; 97(12):1759-64. PubMed ID: 16765130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
    Paterna S; Parrinello G; Cannizzaro S; Fasullo S; Torres D; Sarullo FM; Di Pasquale P
    Am J Cardiol; 2009 Jan; 103(1):93-102. PubMed ID: 19101237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial.
    Triposkiadis FK; Butler J; Karayannis G; Starling RC; Filippatos G; Wolski K; Parissis J; Parisis C; Rovithis D; Koutrakis K; Skoularigis J; Antoniou CK; Chrysohoou C; Pitsavos C; Stefanadis C; Nastas J; Tsaknakis T; Mantziari L; Giannakoulas G; Karvounis H; Kalogeropoulos AP; Giamouzis G
    Int J Cardiol; 2014 Mar; 172(1):115-21. PubMed ID: 24485633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
    Paterna S; Di Pasquale P; Parrinello G; Amato P; Cardinale A; Follone G; Giubilato A; Licata G
    Eur J Heart Fail; 2000 Sep; 2(3):305-13. PubMed ID: 10938493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial).
    Trippel TD; Van Linthout S; Westermann D; Lindhorst R; Sandek A; Ernst S; Bobenko A; Kasner M; Spillmann F; González A; López B; Ravassa S; Pieske B; Paulus WJ; Díez J; Edelmann F; Tschöpe C
    Eur J Heart Fail; 2018 Mar; 20(3):460-470. PubMed ID: 28891228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Intravenous Furosemide Versus a Novel, pH-Neutral Furosemide Formulation Administered Subcutaneously in Outpatients With Worsening Heart Failure.
    Gilotra NA; Princewill O; Marino B; Okwuosa IS; Chasler J; Almansa J; Cummings A; Rhodes P; Chambers J; Cuomo K; Russell SD
    JACC Heart Fail; 2018 Jan; 6(1):65-70. PubMed ID: 29226816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.